The nation of Zimbabwe has rejected a major American health deal worth 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive data.
This move became public following a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesperson later stated that the US was demanding access to biological samples for research and profit while refused to guarantee the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more talks to reach a agreement agreeable to all parties so the country's critical HIV programme can proceed.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and responsibility.
As per reports, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the American exit from the global health body and its push of bilateral deals were upending systems previously established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We welcome further dialogue with our American counterparts on how subsequent co-operation might be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
Medical experts said it acknowledged the government's concerns, but suggested that talks need to persist since much of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group said.
The situation underscores the continuing debate between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.